INTRODUCTION
Iron is an essential cofactor in diverse biological processes such as oxygen transport, electron transport, signal transduction, and DNA synthesis. In mammals, extraintestinal cells such as developing erythrocytes primarily depend on the transferrin (Tf) cycle to acquire iron from the circulation (Andrews, 2008; Hentze et al., 2004; Levy et al., 1999) . Each Tf can bind two ferric iron (Fe 3+ ) molecules. The diferric Tf may interact with transferrin receptor (Tfrc) on the cell surface, followed by internalization through clathrin-mediated endocytosis. During the acidification and maturation of endosomes, iron is reduced by sixtransmembrane epithelial antigen of the prostate member 3 (Steap3) and subsequently exported out of endosomes by divalent metal transporter 1 (Fleming et al., 1998; Gunshin et al., 1997; Ohgami et al., 2005) . This iron may either be delivered to the cytoplasmic iron storage protein ferritin or iron-containing enzymes by poly (rC) binding proteins (Nandal et al., 2011; Shi et al., 2008) , or be imported into the mitochondria for the synthesis of heme and iron sulfur clusters by mitoferrin 1 (Mfrn1, Slc25a37) and its partner Abcb10 in developing erythroblasts Shaw et al., 2006) . The rest of the Tf complex, apo-Tf and Tfrc, are sorted into the recycling endosomes and returned to the cell surface.
The Tf cycle involves three major processes in Tf-Tfrc trafficking: internalization into early endosomes, sorting into recycling endosomes, and recycling to the cell surface (Chen and Paw, 2012; Schultz et al., 2010) . Each of these unidirectional movements is likely to be mediated by specific trafficking machinery. The final step, the trafficking of Tfrc from recycling endosomes to the cell surface, has previously been shown to be mediated by Sec15l1, as its mutation causes anemia in the hemoglobin deficit (hbd) mouse (Lim et al., 2005; White et al., 2005; Zhang et al., 2006) . The sorting mechanisms responsible for earlier trafficking events in the Tf cycle, however, remain poorly understood.
Sorting nexins (Snxs) are a family of phosphoinositide-binding proteins that play critical roles in many cellular pathways including nutrient uptake, signal transduction, and development (Cullen and Korswagen, 2012; Johannes and Popoff, 2008) . They are essential components of retromer complexes that regulate the retrograde protein transport through early endosomes. The classical retromer complex is composed of the cargo-selective component, Vps26-Vps29-Vps35, and a heterodimeric coat formed by Snx1, Snx2, Snx5, and Snx6 (Cullen and Korswagen, 2012; Johannes and Popoff, 2008; Johannes and Wunder, 2011) . Besides these four sorting nexin members, mammals have 29 additional Snxs (Cullen, 2008) . These Snxs may have evolved more specialized functions and may regulate retrograde trafficking in tissue-specific or cargo-selective manners. In vitro cell biological studies have implicated several Snxs, including Snx4, Snx9, Snx15, and Snx18, in regulating Tf uptake and Tfrc internalization (Barr et al., 2000; Park et al., 2010; Traer et al., 2007) ; however, direct evidence is lacking regarding the functional significance of these molecules in mammalian iron physiology.
From an mRNA sequencing experiment, we found that Snx3 is highly expressed in developing red cells and hematopoietic tissues. Given the intriguing role of the Snx family members in intracellular trafficking along with the strong induction of Snx3 during erythroid maturation, we hypothesized a functional role for Snx3 in Tf-mediated iron metabolism. To dissect the biochemical function of Snx3 in red cell development, we utilized loss-offunction studies in zebrafish embryos and mammalian erythroid cells. Our complementary results from genetic, biochemical, and biological studies consistently show that Snx3 regulates Tfrc trafficking and is essential for maintaining vertebrate iron homeostasis.
RESULTS

Snx3 is highly expressed in erythroid tissues
Since maturing erythroblasts consume a large amount of iron for the production of heme and hemoglobin (Andrews, 2008; Richardson et al., 2010) , it is likely that the sorting molecules responsible for Tf-mediated iron uptake would be abundantly expressed in erythroid tissues. To identify candidate trafficking genes involved in erythropoiesis, we analyzed gene expression profiles during red cell differentiation from an mRNA sequencing (RNA-seq) experiment (Wong et al., 2011) . Cells from mouse fetal liver, an organ for definitive erythropoiesis, were sorted by flow cytometry into five distinct sub-populations (R1 to R5), reflecting progressive stages of erythroid maturation (Zhang et al., 2003) . We found that the expression of an endosomal sorting molecule, Snx3, was up-regulated >3.5 fold in all later stages of differentiating erythroblasts relative to primitive progenitor cells ( Figure 1A ). The expression profile of Snx3 is similar to that of Tfrc and heme synthesis genes such as ferrochelatase (Fech), suggesting that they may have coordinated functions. In contrast, no substantial changes in the expression were observed for the genes encoding classical retromer components (Table S1 ). In worms and flies, SNX3 has been shown to control Wnt signaling by regulating the retromer-dependent transport of Wntless, a membrane protein required for Wnt secretion (Harterink et al., 2011; Zhang et al., 2011) . Cell biological studies in human epidermoid carcinoma cells suggest that SNX3 controls endosomal morphology and endocytic cargo transport (Xu et al., 2001) . However, the role of Snx3 in iron homeostasis and vertebrate erythropoiesis is unknown.
To confirm the enriched expression of Snx3 and thus its potential function in hematopoietic tissues, we examined the expression pattern of Snx3 in developing mouse embryos. Consistent with the RNA-seq data, Snx3 was highly expressed in mouse primitive (yolk sac at E8.5) and definitive hematopoietic tissues (fetal liver at E12.5 and E15.5, Figure 1B ). The specificity of Snx3 signal was confirmed by using a negative control gene, which displayed no staining in the bloods islands of mouse embryos ( Figure S1 ). At E15.5, Snx3 was also expressed in heart, lung, kidney, and gut, suggesting that it may play a role, in either iron metabolism or Wnt signaling, in these tissues. To further interrogate the erythroid enrichment profile of Snx3, we chemically differentiated mouse Friend erythroleukemia (MEL) cells with dimethyl sulfoxide (DMSO), and analyzed their protein levels by western analysis. We found that Snx3,as well as the erythroid proteins, Tfrc and Fech,were induced during MEL cell differentiation ( Figures 1C and 1D ). The expression pattern of Snx3 closely resembled that of Tfrc. Both proteins displayed increased abundance in the first 4 days and a moderate reduction at day 5, whereas evident up-regulation for Fech was observed between day 3 and day 5 after chemical differentiation, consistent with the phenomenon that iron acquisition precedes heme synthesis ( Figures 1C and 1D) . In contrast to Snx3 and other erythroid genes, Snx4, a sorting nexin previously implicated in Tfrc trafficking (Traer et al., 2007) , did not show differential expression during erythroid maturation ( Figures 1A, 1C, and 1D ). This indicates that although Snx4 was shown to regulate endosomal sorting of Tfrc in HeLa cells (Traer et al., 2007) , it may not be the primary sorting molecule that regulates Tf-mediated iron uptake in red cells.
To further examine whether the erythroid expression of Snx3 is conserved among higher vertebrates, we performed whole mount in situ hybridization (WISH) analysis on zebrafish embryos. We detected robust expression of snx3 in the intermediate cell mass (ICM), the functional equivalent tissue of the yolk sac blood islands in mammals, in a pattern similar to the erythroid transcription factor gata1 ( Figure 2A ). The ICM expression for snx3 was further verified using cloche, a mutant lacking hematopoietic stem cells and vascular progenitors (Stainier et al., 1995) , and dino, a mutant with expanded blood due to its ventralized phenotype (Hammerschmidt et al., 1996) . Similar to the erythroid markers tfr1a and gata1, zygotic expression of snx3 was first detected in the ICM between 10 and 15-somite stages in zebrafish embryos ( Figure S2A ). Taken together, our data consistently show that the expression of Snx3 is enriched in erythroid tissues of higher vertebrates.
Morpholino knockdown of snx3 produces anemia in zebrafish
To elucidate the role of Snx3 in erythropoiesis, we knocked down snx3 in zebrafish embryos with a translation-blocking morpholino and a pre-mRNA splice-blocking morpholino ( Figure S2B ). Results from reverse transcription PCR (RT-PCR) validated that the injection of the splice-blocking morpholino interfered with the splicing of snx3 pre-mRNA ( Figure   S2C ). Western analysis revealed that both morpholinos specifically reduced the expression of snx3, while the controls, snx4 and α-actin, were unaffected ( Figure 2B ). Knockdown of snx3 in zebrafish embryos resulted in a profound anemia, as indicated by the absence of odianisidine positive hemoglobinized cells, at both 48 and 72 hours post fertilization (hpf) ( Figure 2C ). To determine whether the anemic phenotype was due to impaired heme production or a defect in hematopoiesis, we examined the expression of an erythroid progenitor marker (gata1), a terminal erythroid marker (βe1 globin), and a myeloid lineage marker (myeloperoxidase, mpo). The expression of both gata1 and mpo was normal in snx3-deficient embryos ( Figure S2D ), indicating that neither erythroid nor myeloid specification was affected. We detected robust expression of βe1 globin in snx3-morphant embryos at 48 hpf despite the absence of heme staining (Figures 2C and S2E) , suggesting that these globinexpressing erythrocytes are hypochromic. The morphant embryos, however, exhibited substantial decreases in the red cell numbers at 72 hpf ( Figure S2E ). We confirmed the reduction in erythrocyte number by silencing snx3 in a Tg(globin-LCR:eGFP) transgenic line, which expresses gfp under the globin locus control region (LCR) enhancer (Ganis et al., 2012) . Quantification by flow cytometry revealed a significant reduction in erythrocytes at 72 hpf, while no change in erythroid cell number was observed at 48 hpf ( Figure 2D ), confirming the hypochromic anemia at 48 hpf. The decrease in erythroid cell number at the later stage is likely an outcome of apoptosis due to severe iron deficiency. A similar trend in the expression of βe1 globin has been observed in the zebrafish mutant chianti, which has a tfr1a defect (Wingert et al., 2004) . These results indicate that snx3 is required for hemoglobin synthesis in the erythroid tissues of teleosts.
Silencing of Snx3 results in hemoglobinization defects in mouse hematopoietic cells
To analyze whether Snx3 has a conserved role in mammalian red cell development, we silenced Snx3 in mouse primary fetal liver (MPFL) cells using shRNA hairpins ( Figure 3A) . Consistent with the results in zebrafish, retroviral infection of Snx3 shRNAs resulted in >75% reduction in total hemoglobin content ( Figure 3B ). To further understand the erythroid function of Snx3, we generated two stable MEL cell clones expressing Snx3-shRNAs. Under both undifferentiated and chemically differentiated conditions, Snx3 expression was efficiently silenced ( Figure 3C ). The expression of Snx4 was not affected, validating the specificity of the targeted knockdown by the shRNAs. Results from odianisidine staining revealed severe defects of hemoglobin production in these Snx3-silenced MEL cells ( Figures 3D and 3E ).
Snx3 is required for cellular iron uptake through regulating the trafficking of Tf-Tfrc complex
To determine whether the hemoglobinization defect observed in Snx3-deficient cells is due to impaired uptake and delivery of Tf-bound iron, we labeled the stable shRNA MEL clones with 59 Fe-saturated Tf. We found a reduction in Tf uptake, iron delivery, as well as iron incorporation into heme in Snx3-silenced cells ( Figure 4A ). Interestingly, these cells have normal activities of iron-containing enzymes such as cytosolic xanthine oxidase and mitochondrial aconitase (Figures S3A and S3B) . It is likely that the differentiating erythroid cells may prioritize their limited iron supplies to first fulfill the requirement for the basic cellular processes. In addition, the demand of iron by these processes is much lower than the requirement of iron for heme synthesis in differentiating erythroid cells. When cellular iron is limited, the enzymes involved in basic metabolism such as xanthine oxidase and aconitase may still acquire sufficient amount of iron while less iron is provided for heme production.
To examine whether the reduced iron uptake is due to defective endosomal acidification, a process preceding iron release, we treated the cells with bafilomycin, a specific inhibitor of the vacuolar type H(+)-ATPase (Yoshimori et al., 1991) . Treatment with bafilomycin reduced the uptake of 59 Fe-Tf to a similar extent in both control and Snx3-silenced cells ( Figures 4A and S3C ). In the presence of bafilomycin, the Snx3-silenced cells still maintained a lower uptake of 59 Fe-Tf than the control cells ( Figure 4A ), suggesting that this reduced iron uptake is not due to pH alteration in endosomes. In addition, this reduced Tf uptake is not a consequence of decreased accessibility of its receptor, as evidenced by the normal levels of Tfrc on the surface of Snx3-silenced cells ( Figure 4B ).
The reduction in the uptake of Tf iron, despite the presence of the receptor Tfrc, suggests that the Snx3-silenced cells may have defective vesicular trafficking of the Tf-Tfrc complex.
To characterize the defect in the Tf cycle, we incubated the stable MEL cells with Tf-Alexa 488 and analyzed the subcellular distribution of Tf. We found that in Snx3-silenced cells, the Alexa-labeled Tf accumulated as large intracellular clusters ( Figures 4C, 4D , S3D, and S3E). The clustered Tf signal colocalized with Tfrc as well as Rab5, a marker for the early endosomal compartment, indicating that the internalized Tf complex is trapped in the enlarged early endosomal compartments. In the majority of control cells, no clustered pattern is observed, indicating constant recycling and clearance of the internalized Tf. These results suggest that the endosomal trafficking of Tf is impaired in Snx3-silenced cells.
To quantify the defect on the sorting and recycling of Tf, we pulsed-labeled the Snx3-silenced cells with holo-Tf conjugated with fluorescent Alexa 647, and measured the kinetics of Tf release following the chase with unlabeled Tf. As shown in Figure 4E , silencing of Snx3 significantly delayed the recycling of internalized Tf. The t 1/2 of Tf release was >30% longer in the Snx3-silenced cells (9.99 ± 0.34 min and 10.08 ± 0.68 min for the two shRNA clones) than that in the control clone (7.36 ± 0.4 min). These data indicate that Snx3 is required for the efficient recycling of Tf-Tfrc complex.
Silencing of Snx3 reduces the turnover rate of Tfrc
Previously, it was observed that suppression of Tfrc recycling accelerated its degradation by lysosomes in HeLa cells (Traer et al., 2007) . Is the Tfrc accumulated in the early endosomes of Snx3-silenced cells more likely to be degraded? Is Tfrc expression altered in response to potential changes in its stability as well as cellular iron deficiency in these cells? To address these questions, we rigorously examined the steady state level, the synthesis rate, and the degradation rate of Tfrc protein. Results from immunoblotting analysis revealed a moderate decrease in Tfrc protein abundance in Snx3-silenced clones, suggesting reduced Tfrc expression ( Figures 5A and 5B) . Consistent with this observation, the silencing of Snx3 produced a severe reduction of ~3.8 fold in Tfrc mRNA levels in MEL cells ( Figure 5C ). The Tfrc mRNA has five iron regulatory elements (IREs) in its 3′ untranslated region (UTR), and iron deficiency would in general induce its expression by stabilizing the mRNA by iron regulatory proteins (IRPs) (Casey et al., 1988) . In erythroid cells, however, the Tfrc expression is regulated by mechanisms that are independent of the IRE/IRP system ( Chan et al., 1994; Ponka and Lok, 1999; Schranzhofer et al., 2006) (Figures 5Dand 5 E) . In addition, the rate of Tfrc degradation following pulse-chase was also lower (~3.1 fold) in Snx3-silenced clones ( Figures 5D and 5E ), suggesting that the Tf complex accumulated in the endosomal compartments is not missorted into lysosomes for degradation. In contrast to Tfrc, the steady state levels of other proteins that traffic through the endosomal compartments, such as Snap23 and Lamp1 (Cook et al., 2004; Valdez et al., 1999) , were not significantly altered ( Figures S5A and S5B) . These results indicate that the abnormal expression and stability of Tfrc is not due to a global delay in the progression to lysosomes. Thus, Snx3-silenced cells have a reduced turnover rate as well as defective trafficking of Tfrc.
Snx3 interacts with Tfrc in an oligomeric complex
Our findings suggest that when Tf-Tfrc complex transits through the early endosomes, it may transiently associate with Snx3 in order to be sorted to the recycling endosomes. To test this hypothesis, we transiently co-expressed Snx3 and FLAG-tagged Tfrc in heterologous HEK293 cells and affinity purified the protein complex associated with Tfrc using anti-FLAG beads. The known mitochondrial transmembrane protein Abcb10 was used as a control for nonspecific interactions between membrane-associated proteins Shirihai et al., 2000) . We detected a significantly higher quantity of Snx3 that was associated with Tfrc than Abcb10 ( Figure 6A ). To exclude the potential artifact from ectopic over-expression studies, we performed the pull-down assays in MEL cells that stably express either Tfrc-FLAG or Abcb10-FLAG driven by the promoter of eukaryotic translation elongation factor 1α. Under both undifferentiated and DMSO-induced conditions, endogenous Snx3 specifically interacted with Tfrc ( Figure 6B ). In addition, Tfrc, but not Abcb10, was able to pull down Vps35, the cargo-selective component of the retromer complex. These data therefore demonstrate that Snx3, together with other retromer complex components, regulates the endocytic recycling of Tf-Tfrc complex through physical interaction with Tfrc.
The heme defects due to Snx3 deficiency are rescued by supplementation with non-Tf bound iron-chelates
To demonstrate the functional specificity of Tfr-dependent iron uptake pathway affected by Snx3 deficiency, we tested whether supplementation of non-Tf bound iron-chelates could complement the hemoglobinization defect in Snx3-silenced cells and zebrafish embryos. It has been previously reported that iron conjugated with salicylaldehyde isonicotinoyl hydrazone (Fe-SIH) could be taken up by erythroid cells through a Tfrc-independent pathway (Garrick et al., 1991; Zhang et al., 2006) . Supplementation of ferric citrate (Fecitrate), Fe-SIH, or a related chemically-defined iron supplement (Sigma-Aldrich I3153, Fechelate mixture, containing EDTA, citrate, and salicylic acid derivative) all increased the population of o-dianisidine positive cells by 2-5 fold in Snx3-silenced MEL clones ( Figures   7A and S6) . The rescue effects of these iron compounds were further confirmed in zebrafish in vivo. Here we took advantage of the observation that snx3 morphant embryos have reduced number of erythrocytes at 72 hpf, an outcome of apoptosis induced by severe iron deficiency, and rigorously quantified the effects of the non-Tf iron-chelate supplements by flow cytometry ( Figure 2D ). We found that these iron-chelate supplements increased the number of erythrocytes, as indicated by GFP fluorescence, in snx3-silenced Tg(globin-LCR:eGFP) embryos ( Figure 7B ). The gene encoding the mitochondrial iron importer mitoferrin-1 (slc25a37), mfrn1, was used as a control since its knockdown was known to induce hypochromic anemia due to iron deficiency (Shaw et al., 2006) . The chemical complementation with the iron-chelate compounds reinforces our proposed model that Snx3 specifically regulates Tfrc-dependent iron assimilation in red cell development.
DISCUSSION
Our study demonstrates that Snx3 regulates endocytic recycling of Tfrc, and thus plays a critical role in cellular iron homeostasis and erythropoiesis in vertebrates ( Figure 7C ). The yeast homolog of Snx3, Grd19p, has been shown to mediate the endocytic recycling of Fet3p-Ftr1p, a yeast-specific reductive iron transporter system, through direct interaction with Ftr1p (Strochlic et al., 2008; Strochlic et al., 2007) . Taken together, Snx3 may play a regulatory role in iron homeostasis across multiple eukaryotic phyla.
Snx3 is highly expressed in hematopoietic tissues of zebrafish and mouse. To account for the enrichment of Snx3 mRNA in blood islands and the increase in Snx3 protein expression in differentiating MEL cells, we searched GATA-1 and EKLF/KLF1 ChIP-seq databases to determine if Snx3 could be regulated by key transcriptional regulators of erythropoiesis. As predicted, the Snx3 gene is bound by EKLF/KLF1 (Tallack et al., 2010) and GATA-1 (Yu et al., 2009) in vivo. In addition to the regulation at the transcriptional level, the mouse Snx3 also has a predicted IRE-like structure in the 3′ UTR of its mRNA (5′-CGCUGUGUCCGUGUGCACACUG-3′) (Campillos et al., 2010) . The abundance of Snx3 mRNA, however, showed no changes in response to either iron depletion with desferrioxamine or iron overload with 200 μM ferric citrate ( Figure S7 ), suggesting that the putative IRE is not functional. Furthermore, the putative 3'UTR IRE is not conserved in other vertebrate Snx3 orthologs.
Snx3 has been shown to interact with Vps35, the cargo-selective component of retromer (Vardarajan et al., 2012; Zhang et al., 2011) . In addition, a proteomic study in yeast detected interactions between Grd19p and Sec15p (Vollert and Uetz, 2004) , whose ortholog in mammals was shown to control the sorting of Tf-Tfrc complexes in recycling endosomes (Lim et al., 2005; White et al., 2005; Zhang et al., 2006 ). Here we found that Tfrc physically interacts with both Snx3 and Vps35. These data indicate that Snx3 and the Vps proteins may constitute a non-classical retromer complex that interacts with Tf-Tfrc oligomers in early endosomes and deliver them to Sec15l1 in recycling endosomes ( Figure 7C ).
The important role of Snx3 in Tf trafficking was independently validated by studies in mammalian hematopoietic cells. Silencing of Snx3 reduced the rate of Tf recycling and the uptake of Tf-bound iron (Figures 4A and 4E) . In Snx3-silenced cells, the internalized Tf accumulated as large intracellular clusters in the early endosomes ( Figures 4C and 4D ). This defective trafficking may be responsible for the reduced turnover rate of Tfrc protein ( Figure  5 ). Interestingly, although the Snx3-silenced cells had an increased level of Tf-Tfrc complexes in the enlarged early endosomes and a reduced amount of total cellular Tfrc, we did not find any reduction in the cell surface-bound Tfrc ( Figure 4B ). The normal level of Tfrc on the cell surface may be maintained by such factors as the extended stability of Tfrc and the likely reduced internalization rate of Tfrc. The reduced internalization accompanying reduced recycling has been observed for Sec15l1, which also plays a regulatory role in the Tf cycle (Zhang et al., 2006) . Our data further suggest that the defective Tf trafficking due to Snx3 deficiency may have altered the distribution of Tfrc between the early and the recycling endosomes, whereas the Tfrc abundance on the cell surface may not be as directly impacted. Further investigation may be needed to test these possibilities and to fully characterize the steady-state equilibrium of Tfrc in the Snx3-silenced cells.
In nonerythroid cells, the interaction of Snx3 with Tfrc may be functionally substituted by other receptors, implying a broader role for Snx3 in retromer-mediated vesicular recycling. Two independent reports have shown that Snx3 mediates the retrograde transport of the Wnt sorting receptor Wntless and is required for Wnt secretion in flies and worms (Harterink et al., 2011; Zhang et al., 2011) . The involvement of Snx3 in two discrete cellular pathways suggests that it regulates the endosomal sorting of a repertoire of cargo receptors including Tfrc and Wntless, and thus plays a fundamental role in intracellular vesicle trafficking.
The fundamental role of Snx3 in endosomal sorting was further attested by its involvement in the retrograde trafficking of amyloid precursor protein (APP) (Vardarajan et al., 2012) . Through analyzing a genome-wide association study (GWAS) dataset, this study identified significant association between the single nucleotide polymorphisms (SNPs) in SNX3 and Alzheimer disease. Results from this study further indicated that SNX3 and VPS proteins form a retromer complex that mediates the retrieval of APP from endosomes to Golgi, thus preventing the generation of the neurotoxic amyloid β peptide. In addition, another research group located a SNX3 gene disruption in a patient with microcephaly, microphthalmia, ectrodactyly, and prognathism (MMEP) (Vervoort et al., 2002) . However, no mutations in the coding region of SNX3 were found in five additional patients with MMEP, suggesting that the defect in SNX3 may not be responsible for the MMEP phenotype (Kumar et al., 2007) .
Given the profound anemic phenotype in snx3-silenced zebrafish embryos, it is also likely that mutations in SNX3 may lead to hematological disorders in humans. We therefore searched the NHGRI human GWAS databases (Hindorff et al., 2009 ), but we were not able to find a significant association between SNX3 SNPs and the hematologic traits (Ganesh et al., 2009; Soranzo et al., 2009) . Two SNPs that are associated with hematologic traits located in the same cytoband as SNX3, rs11966072 and rs4947019, are located at a considerable distance (>1 Mb) from the SNX3 locus, making them unlikely disease causing candidates in SNX3. Further genetic and sequencing studies on anemic patients with undefined etiologies may help to reveal the potential connection between SNX3 and hematological disorders. Thus, the identification of Snx3, as an essential co-regulatory protein that regulates Tf-mediated iron delivery for heme synthesis, provides a genetic tool for exploring erythropoiesis and human disorders of iron metabolism, such as the hypochromic anemias.
EXPERIMENTAL PROCEDURES Zebrafish Experiments
All zebrafish experiments were performed in compliance with the Institutional Animal Care and Use Committee (IACUC) regulations at Boston Children's Hospital. AB, cloche (clo m39 ) (Stainier et al., 1995) , dino (din tm84 ) (Hammerschmidt et al., 1996) , and Tg(globin-LCR:eGFP) (Ganis et al., 2012) transgenic lines were used in this study. Whole-mount in situ hybridization was carried out as previously described (Amigo et al., 2011 ). An ATGblocking and a splice-blocking anti-sense morpholinos for snx3 were obtained from Gene Tools (Supplemental Information), and each MO was individually injected into one-cell stage zebrafish embryos. The embryos were harvested at 24~72 hpf for WISH and 48~72 hpf for o-dianisidine staining, following the protocols described previously (Shaw et al., 2006) . Flow cytometry on the Tg(globin LCR:eGFP) embryos was preformed as previously described (Cooney et al., 2013) .
Knock down of Snx3 in mouse cells
shRNA constructs (Supplemental Information) were purchased from Sigma-Aldrich. Stable Snx3-silenced MEL clones were generated by electroporation, followed by selection with puromycin. Snx3 was silenced in MPFL cells by infection with retroviruses containing shRNAs for Snx3 (Hattangadi et al., 2010) . The knockdown efficiency was examined by immunoblotting analysis. The hemoglobin in stable MEL cells was stained with odianisidine, and the hemoglobin content in MPFL was measured with Drabkin's reagent (Hattangadi et al., 2010) .
Transferrin uptake and immunofluorescence assays
Stable Snx3-silenced MEL clones were labeled with 59 Fe-transferrin as previously described (Zhang et al., 2006) . 59 FeCl 3 (specific activity: 42.59 mCi/mg) was obtained from PerkinElmer. The MEL cells were also incubated with transferrin-Alexa 488 followed by immunofluorescence studies using antibodies against Tfrc and Rab5.
Metabolic [ 35 S]-labeling
Stable Snx3-silenced MEL cells were labeled with L-[ 35 S]methionine and L-[ 35 S]cysteine (PerkinElmer, >1,000 Ci/mmol specific activity) following a protocol described previously (Paradkar et al., 2009) . The abundance of [ 35 S]-labeled Tfrc was examined at different time during both pulse and pulse-chase phases.
Tfrc pull-down assays
The FLAG-tagged Tfrc and Abcb10 constructs were generated using the same strategy as previously reported . MEL clones stably expressing Tfrc-FLAG or Abcb10-FLAG were generated by electroporation followed by puromycin selection. Cell lysates from the stable MEL cells or HEK293 cells transiently transfected with Snx3 plasmids in combination with Tfrc-FLAG or Abcb10-FLAG were subjected to FLAG pulldown assays using ANTI-FLAG M2 Affinity Gel .
Iron supplementation experiments
A chemically defined iron supplement (Sigma-Aldrich, I3153; EC #231-791-2), 20 μM Fe-SIH, or 20 μM Fe-citrate was supplemented to MEL cells during the erythroid-like induction. The embryos from Tg(globin-LCR:eGFP) transgenic zebrafish were injected with morpholinos against snx3 or the positive control mfrn1. These zebrafish embryos were treated with the chemically defined iron supplement or 10 μM Fe-SIH at 30 hpf, and were analyzed for the percentage of erythrocytes based on GFP fluorescence by flow cytometry at 72 hpf.
Statistical analysis
All data are presented as mean ± standard error of the mean (SEM). Statistical significance was tested using one-way ANOVA followed by the Tukey-Kramer Multiple Comparisons Test in GraphPad INSTAT version 3.01 (GraphPad, San Diego, CA, USA). A P value of < 0.05 was considered as statistically significant.
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Refer to Web version on PubMed Central for supplementary material. control genes in the five erythroid sub-populations sorted from mouse fetal liver at E12-16 (Wong et al., 2011) . The arrow on the top indicates the process of red cell maturation with R1 population representing primitive progenitor cells and proerythroblasts and R5 population representing late orthochromatophilic erythroblasts and reticulocytes (Zhang et al., 2003) . (B) Snx3 transcripts are enriched in mouse hematopoietic tissues. In situ hybridization revealed robust expression of Snx3 in the yolk sac (YS) blood islands at E8.5 and fetal liver (FL) at E12.5 and E15.5. At E15.5, Snx3 is also expressed in heart (H), lung . The experiments were performed in one replicate. Linear regression models were fitted to the data, and the slopes were indicated as +k or −k for the rates of synthesis or degradation, respectively. (A) Protein pull-down assays in a heterologous system indicate interactions between Snx3 and Tfrc. Cell lysates from HEK293 cells ectopically expressing Tfrc-FLAG or the control Abcb10-FLAG combined with Snx3 were purified with anti-FLAG beads followed by western analysis. The western blots of whole cell lysates (protein input) and the binding fractions (FLAG elution, 30×) are presented. (B) Tfrc interacts with both Snx3 and Vps35 in MEL cells. MEL cells stably expressing Tfrc-FLAG or the control Abcb10-FLAG were subjected to the protein pull-down assays. The endogenous Snx3 and Vps35 copurified with Tfrc-FLAG, but not with Abcb10-FLAG. (A) Fe-SIH, ferric citrate, and a chemically defined iron supplement increase the hemoglobin production in Snx3-silenced MEL cells after chemically induced differentiation.
Error bars represent SEM from three independent experiments. *P < 0.001 compared with the control clone; †P < 0.05 compared with the DMSO control within the group. (B) Fe-SIH and a chemically defined iron supplement restore the number of erythrocytes in snx3 morphant zebrafish embryos at 72 hpf. Mitoferrin1 (mfrn) is used as a positive control for iron rescue. Error bars represent SEM from two independent experiments. *P < 0.001 compared with the control morpholino; †P < 0.05 compared with the untreated embryos. (C) The proposed role of Snx3 in Tf cycle. In early endosomes, Snx3, along with Vps35, transiently interacts with and sorts the Tf-Tfrc complex into recycling endosomes. Sec15l1 regulates the trafficking of Tf-Tfrc complex from recycling endosomes to cell surface. ISCs, iron sulfur clusters.
